Auron Healthcare GmbH Report issue

For profit Phase 3
Founded: Freiburg Germany (2007)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

oxaliplatin (eloxatin) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 2)

Colorectal Neoplasms (Phase 3)

Gastrointestinal Neoplasms (Phase 3)

Genital Neoplasms, Female (Phase 3)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1